Lv6
2478 积分 2021-10-19 加入
Liver metastases
1天前
待确认
Synthetic manipulation of the cancer-immunity cycle: CAR-T cell therapy
2天前
待确认
The cell stress and immunity cycle in cancer: Toward next generation of cancer immunotherapy
2天前
已完结
Resistance mechanisms to immune checkpoint inhibitors: updated insights
2天前
已完结
Multispecific Antibodies Targeting PD-1/PD-L1 in Cancer
2天前
已完结
Navigating established and emerging biomarkers for immune checkpoint inhibitor therapy
2天前
已完结
Turning cold into hot: emerging strategies to fire up the tumor microenvironment
2天前
已完结
Targeting novel immune checkpoints in the B7-H family: advancing cancer immunotherapy from bench to bedside
2天前
已完结
Tislelizumab: First Approval
3天前
已完结
Understanding and overcoming resistance to PARP inhibitors in cancer therapy
4天前
已完结
皖公网安备34019202002308
